The Effects of Subcutaneously Injected Novel Biphasic Cross-Linked Hyaluronic Acid Filler: In Vivo Study
Background Biphasic hyaluronic acid (HA) fillers have been used extensively to improve facial skin. However, in some cases, the skin surface is irregular because of the premature loss of HA solution. We propose a new biphasic filler (G-filler) to overcome this problem by using small particles of HA...
Gespeichert in:
Veröffentlicht in: | Aesthetic plastic surgery 2021-02, Vol.45 (1), p.322-331 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 331 |
---|---|
container_issue | 1 |
container_start_page | 322 |
container_title | Aesthetic plastic surgery |
container_volume | 45 |
creator | Hahn, Hyung Min Lee, Woo Beom Lee, Il Jae |
description | Background
Biphasic hyaluronic acid (HA) fillers have been used extensively to improve facial skin. However, in some cases, the skin surface is irregular because of the premature loss of HA solution. We propose a new biphasic filler (G-filler) to overcome this problem by using small particles of HA hydrogel instead of HA solution, which can provide a smooth skin surface and good durability.
Method
We evaluated the rheologic properties of G-filler and its physiologic effects after subcutaneous injection in a mouse model by histologic analysis.
Results
The G-filler showed a similar elastic modulus (G′) and complex viscosity (
η
*) as the conventional biphasic filler, but had a higher viscous modulus (G″) than the conventional monophasic filler. The highest material elasticity (tan
δ
) value and the lowest percentage elasticity value indicate the rheologic properties of G-filler are closer to those of liquids. After subcutaneous injection of G-filler, collagen content (~ 2-fold) and elastin fibers (~ 6.5-fold) were significantly increased at 12 weeks compared to those of the saline group. Fibronectin (~ 2.6-fold) and the laminin-immunolabeled cell number (~ 6-fold) were also significantly increased at 12 weeks. Significant increases in the CD31-immunoreactive cell numbers of the G-filler groups were observed at 2, 6, and 12 weeks (~ 3.7-fold) compared to those of the saline groups. There were no significant differences between the G-filler and saline groups in patterns of skin thickness and inflammatory cell numbers around loading sites.
Conclusion
These findings demonstrate that the injection of a new biphasic filler with improved rheologic properties can effectively stimulate extracellular matrix production and angiogenesis without safety concerns.
No Level Assigned
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors -
www.springer.com/00266
. |
doi_str_mv | 10.1007/s00266-020-02033-1 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2459624100</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2489910404</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-2755e5d882ef3041931d8bb1b41a83c958aafac424a672fcac83985009d97d633</originalsourceid><addsrcrecordid>eNp9kctOwzAQRS0EgvL4ARbIEhs2hvEjccIOKkqRKli0IHaW4zg0JU2KnSD173EJD4kFC8uS77kznrkIHVM4pwDywgOwOCbAYHM4J3QLDajgjERM0G00AB4Lwmj8vIf2vV8AUCal2EV7nFMpIJYDNJ_NLb4pCmtaj5sCT7vMdK2ubdP5ao3v6kVQbI7vm3db4etyNde-NHjoGu_JpKxfgzZe66pzTR3er0yZ41FZVdZdBjN-Kt8bPG27fH2IdgpdeXv0dR-gx9HNbDgmk4fbu-HVhBguo5YwGUU2ypOE2YKDoCmneZJlNBNUJ9ykUaJ1oY1gQseSFUabhKdJBJDmqcxjzg_QWV935Zq3zvpWLUtvbFX1MykmojQO6wEI6OkfdNF0rg6_C1SSphQEiECxnjKbmZ0t1MqVS-3WioLa5KD6HFTIQH3moGgwnXyV7rKlzX8s34sPAO8BH6T6xbrf3v-U_QDn_5Fw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2489910404</pqid></control><display><type>article</type><title>The Effects of Subcutaneously Injected Novel Biphasic Cross-Linked Hyaluronic Acid Filler: In Vivo Study</title><source>MEDLINE</source><source>Springer Online Journals Complete</source><creator>Hahn, Hyung Min ; Lee, Woo Beom ; Lee, Il Jae</creator><creatorcontrib>Hahn, Hyung Min ; Lee, Woo Beom ; Lee, Il Jae</creatorcontrib><description>Background
Biphasic hyaluronic acid (HA) fillers have been used extensively to improve facial skin. However, in some cases, the skin surface is irregular because of the premature loss of HA solution. We propose a new biphasic filler (G-filler) to overcome this problem by using small particles of HA hydrogel instead of HA solution, which can provide a smooth skin surface and good durability.
Method
We evaluated the rheologic properties of G-filler and its physiologic effects after subcutaneous injection in a mouse model by histologic analysis.
Results
The G-filler showed a similar elastic modulus (G′) and complex viscosity (
η
*) as the conventional biphasic filler, but had a higher viscous modulus (G″) than the conventional monophasic filler. The highest material elasticity (tan
δ
) value and the lowest percentage elasticity value indicate the rheologic properties of G-filler are closer to those of liquids. After subcutaneous injection of G-filler, collagen content (~ 2-fold) and elastin fibers (~ 6.5-fold) were significantly increased at 12 weeks compared to those of the saline group. Fibronectin (~ 2.6-fold) and the laminin-immunolabeled cell number (~ 6-fold) were also significantly increased at 12 weeks. Significant increases in the CD31-immunoreactive cell numbers of the G-filler groups were observed at 2, 6, and 12 weeks (~ 3.7-fold) compared to those of the saline groups. There were no significant differences between the G-filler and saline groups in patterns of skin thickness and inflammatory cell numbers around loading sites.
Conclusion
These findings demonstrate that the injection of a new biphasic filler with improved rheologic properties can effectively stimulate extracellular matrix production and angiogenesis without safety concerns.
No Level Assigned
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors -
www.springer.com/00266
.</description><identifier>ISSN: 0364-216X</identifier><identifier>EISSN: 1432-5241</identifier><identifier>DOI: 10.1007/s00266-020-02033-1</identifier><identifier>PMID: 33174067</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Aging ; Angiogenesis ; Animals ; Collagen ; Cosmetic Techniques ; Dermal Fillers ; Elasticity ; Extracellular matrix ; Fibroblasts ; Hyaluronic Acid ; Hydrogels ; Injections, Subcutaneous ; Medicine ; Medicine & Public Health ; Mice ; Original Article ; Otorhinolaryngology ; Plastic Surgery ; Skin ; Viscosity</subject><ispartof>Aesthetic plastic surgery, 2021-02, Vol.45 (1), p.322-331</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature and International Society of Aesthetic Plastic Surgery 2020</rights><rights>Springer Science+Business Media, LLC, part of Springer Nature and International Society of Aesthetic Plastic Surgery 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-2755e5d882ef3041931d8bb1b41a83c958aafac424a672fcac83985009d97d633</citedby><cites>FETCH-LOGICAL-c375t-2755e5d882ef3041931d8bb1b41a83c958aafac424a672fcac83985009d97d633</cites><orcidid>0000-0002-9478-6969</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00266-020-02033-1$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00266-020-02033-1$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33174067$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hahn, Hyung Min</creatorcontrib><creatorcontrib>Lee, Woo Beom</creatorcontrib><creatorcontrib>Lee, Il Jae</creatorcontrib><title>The Effects of Subcutaneously Injected Novel Biphasic Cross-Linked Hyaluronic Acid Filler: In Vivo Study</title><title>Aesthetic plastic surgery</title><addtitle>Aesth Plast Surg</addtitle><addtitle>Aesthetic Plast Surg</addtitle><description>Background
Biphasic hyaluronic acid (HA) fillers have been used extensively to improve facial skin. However, in some cases, the skin surface is irregular because of the premature loss of HA solution. We propose a new biphasic filler (G-filler) to overcome this problem by using small particles of HA hydrogel instead of HA solution, which can provide a smooth skin surface and good durability.
Method
We evaluated the rheologic properties of G-filler and its physiologic effects after subcutaneous injection in a mouse model by histologic analysis.
Results
The G-filler showed a similar elastic modulus (G′) and complex viscosity (
η
*) as the conventional biphasic filler, but had a higher viscous modulus (G″) than the conventional monophasic filler. The highest material elasticity (tan
δ
) value and the lowest percentage elasticity value indicate the rheologic properties of G-filler are closer to those of liquids. After subcutaneous injection of G-filler, collagen content (~ 2-fold) and elastin fibers (~ 6.5-fold) were significantly increased at 12 weeks compared to those of the saline group. Fibronectin (~ 2.6-fold) and the laminin-immunolabeled cell number (~ 6-fold) were also significantly increased at 12 weeks. Significant increases in the CD31-immunoreactive cell numbers of the G-filler groups were observed at 2, 6, and 12 weeks (~ 3.7-fold) compared to those of the saline groups. There were no significant differences between the G-filler and saline groups in patterns of skin thickness and inflammatory cell numbers around loading sites.
Conclusion
These findings demonstrate that the injection of a new biphasic filler with improved rheologic properties can effectively stimulate extracellular matrix production and angiogenesis without safety concerns.
No Level Assigned
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors -
www.springer.com/00266
.</description><subject>Aging</subject><subject>Angiogenesis</subject><subject>Animals</subject><subject>Collagen</subject><subject>Cosmetic Techniques</subject><subject>Dermal Fillers</subject><subject>Elasticity</subject><subject>Extracellular matrix</subject><subject>Fibroblasts</subject><subject>Hyaluronic Acid</subject><subject>Hydrogels</subject><subject>Injections, Subcutaneous</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Mice</subject><subject>Original Article</subject><subject>Otorhinolaryngology</subject><subject>Plastic Surgery</subject><subject>Skin</subject><subject>Viscosity</subject><issn>0364-216X</issn><issn>1432-5241</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kctOwzAQRS0EgvL4ARbIEhs2hvEjccIOKkqRKli0IHaW4zg0JU2KnSD173EJD4kFC8uS77kznrkIHVM4pwDywgOwOCbAYHM4J3QLDajgjERM0G00AB4Lwmj8vIf2vV8AUCal2EV7nFMpIJYDNJ_NLb4pCmtaj5sCT7vMdK2ubdP5ao3v6kVQbI7vm3db4etyNde-NHjoGu_JpKxfgzZe66pzTR3er0yZ41FZVdZdBjN-Kt8bPG27fH2IdgpdeXv0dR-gx9HNbDgmk4fbu-HVhBguo5YwGUU2ypOE2YKDoCmneZJlNBNUJ9ykUaJ1oY1gQseSFUabhKdJBJDmqcxjzg_QWV935Zq3zvpWLUtvbFX1MykmojQO6wEI6OkfdNF0rg6_C1SSphQEiECxnjKbmZ0t1MqVS-3WioLa5KD6HFTIQH3moGgwnXyV7rKlzX8s34sPAO8BH6T6xbrf3v-U_QDn_5Fw</recordid><startdate>20210201</startdate><enddate>20210201</enddate><creator>Hahn, Hyung Min</creator><creator>Lee, Woo Beom</creator><creator>Lee, Il Jae</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9478-6969</orcidid></search><sort><creationdate>20210201</creationdate><title>The Effects of Subcutaneously Injected Novel Biphasic Cross-Linked Hyaluronic Acid Filler: In Vivo Study</title><author>Hahn, Hyung Min ; Lee, Woo Beom ; Lee, Il Jae</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-2755e5d882ef3041931d8bb1b41a83c958aafac424a672fcac83985009d97d633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Aging</topic><topic>Angiogenesis</topic><topic>Animals</topic><topic>Collagen</topic><topic>Cosmetic Techniques</topic><topic>Dermal Fillers</topic><topic>Elasticity</topic><topic>Extracellular matrix</topic><topic>Fibroblasts</topic><topic>Hyaluronic Acid</topic><topic>Hydrogels</topic><topic>Injections, Subcutaneous</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Mice</topic><topic>Original Article</topic><topic>Otorhinolaryngology</topic><topic>Plastic Surgery</topic><topic>Skin</topic><topic>Viscosity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hahn, Hyung Min</creatorcontrib><creatorcontrib>Lee, Woo Beom</creatorcontrib><creatorcontrib>Lee, Il Jae</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Aesthetic plastic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hahn, Hyung Min</au><au>Lee, Woo Beom</au><au>Lee, Il Jae</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Effects of Subcutaneously Injected Novel Biphasic Cross-Linked Hyaluronic Acid Filler: In Vivo Study</atitle><jtitle>Aesthetic plastic surgery</jtitle><stitle>Aesth Plast Surg</stitle><addtitle>Aesthetic Plast Surg</addtitle><date>2021-02-01</date><risdate>2021</risdate><volume>45</volume><issue>1</issue><spage>322</spage><epage>331</epage><pages>322-331</pages><issn>0364-216X</issn><eissn>1432-5241</eissn><abstract>Background
Biphasic hyaluronic acid (HA) fillers have been used extensively to improve facial skin. However, in some cases, the skin surface is irregular because of the premature loss of HA solution. We propose a new biphasic filler (G-filler) to overcome this problem by using small particles of HA hydrogel instead of HA solution, which can provide a smooth skin surface and good durability.
Method
We evaluated the rheologic properties of G-filler and its physiologic effects after subcutaneous injection in a mouse model by histologic analysis.
Results
The G-filler showed a similar elastic modulus (G′) and complex viscosity (
η
*) as the conventional biphasic filler, but had a higher viscous modulus (G″) than the conventional monophasic filler. The highest material elasticity (tan
δ
) value and the lowest percentage elasticity value indicate the rheologic properties of G-filler are closer to those of liquids. After subcutaneous injection of G-filler, collagen content (~ 2-fold) and elastin fibers (~ 6.5-fold) were significantly increased at 12 weeks compared to those of the saline group. Fibronectin (~ 2.6-fold) and the laminin-immunolabeled cell number (~ 6-fold) were also significantly increased at 12 weeks. Significant increases in the CD31-immunoreactive cell numbers of the G-filler groups were observed at 2, 6, and 12 weeks (~ 3.7-fold) compared to those of the saline groups. There were no significant differences between the G-filler and saline groups in patterns of skin thickness and inflammatory cell numbers around loading sites.
Conclusion
These findings demonstrate that the injection of a new biphasic filler with improved rheologic properties can effectively stimulate extracellular matrix production and angiogenesis without safety concerns.
No Level Assigned
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors -
www.springer.com/00266
.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>33174067</pmid><doi>10.1007/s00266-020-02033-1</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-9478-6969</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0364-216X |
ispartof | Aesthetic plastic surgery, 2021-02, Vol.45 (1), p.322-331 |
issn | 0364-216X 1432-5241 |
language | eng |
recordid | cdi_proquest_miscellaneous_2459624100 |
source | MEDLINE; Springer Online Journals Complete |
subjects | Aging Angiogenesis Animals Collagen Cosmetic Techniques Dermal Fillers Elasticity Extracellular matrix Fibroblasts Hyaluronic Acid Hydrogels Injections, Subcutaneous Medicine Medicine & Public Health Mice Original Article Otorhinolaryngology Plastic Surgery Skin Viscosity |
title | The Effects of Subcutaneously Injected Novel Biphasic Cross-Linked Hyaluronic Acid Filler: In Vivo Study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T15%3A50%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Effects%20of%20Subcutaneously%20Injected%20Novel%20Biphasic%20Cross-Linked%20Hyaluronic%20Acid%20Filler:%20In%20Vivo%20Study&rft.jtitle=Aesthetic%20plastic%20surgery&rft.au=Hahn,%20Hyung%20Min&rft.date=2021-02-01&rft.volume=45&rft.issue=1&rft.spage=322&rft.epage=331&rft.pages=322-331&rft.issn=0364-216X&rft.eissn=1432-5241&rft_id=info:doi/10.1007/s00266-020-02033-1&rft_dat=%3Cproquest_cross%3E2489910404%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2489910404&rft_id=info:pmid/33174067&rfr_iscdi=true |